Replay available

Atomera (NASDAQ:ATOM) Q4 2021 Earnings Call

Atomera (NASDAQ:ATOM) Q4 2021 earnings call, held 2022-02-15. Watch the replay and read the transcript on 6ix.

Tue, February 15, 2022 at 5:00 PMendedReplay
Atomera (NASDAQ:ATOM) Q4 2021 Earnings Call
Company
Atomera Incorporated (NASDAQ:ATOM)
Period
Q4 2021 earnings call
Date
Tue, Feb 15, 2022, 5:00 PM ET
Replay
Watch the replay on this page · 41 min
Results news release
Atomera Provides Fourth Quarter and Fiscal 2021 Results · Tue, Feb 15, 2022

On 6ix: 6ix.com/event/atomera-incorporated-atom-q4-2021-earnings-call

Replay

Transcript

Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.

0:00 Hello, everyone, and welcome to Adamera's fourth quarter fiscal year 2021 update call. I would like to remind everyone that this call and webinar are being recorded, and a replay will be available on Adamera's IR website for the one year. I'm Mike Bishop with the company's investor relations. As in prior quarters, we are using Zoom, and we will follow a similar format with participants in a listen-only mode. We will open the call with prepared remarks from Scott Bibaud at Ameris President and CEO and Frank Laurencio at Ameris CFO. Then we will open the call to questions. If you are joining by telephone, you may follow a slide presentation to accompany our remarks on the events and presentation section of our investor relations page on our website.

0:45 Before we begin, I would like to remind everyone that during today's call, we will make forward looking statements. These forward looking statements, whether in prepared remarks or during the Q&A session are subject to inherent risks and uncertainties. These risks and uncertainties are detailed in the risk factors section of our filings with the Securities and Exchange Commission, specifically in the company's annual report on Form 10-K filed with the SEC on February 15, 2022. Except as otherwise required by the federal securities laws, Atomer just claims any obligation to update or make revisions to such forward-looking statements contained herein or elsewhere to reflect changes in expectations with regards to those events, conditions, and circumstances. Also, please note that during this call, we will be discussing non-GAAP financial measures as defined by SEC Regulation G. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in today's press release, which is posted on our website. Now, I would like to turn the call over to our President and CEO, Scott Bibaud. Go ahead, Scott.

1:51 Thanks, Mike. Good afternoon and welcome to Adam Harris update call for Q4 2021. We've had a very eventful three months, capped by our recent announcements of an integration license with a foundry and progress on our JDA. If you've been following us for any length of time, you know that large semiconductor companies are not fast moving. A week ago, we announced our fifth license agreement, an integration license with a foundry partner. This builds on the license agreements with AKM, NFC Micro, plus another unnamed partner, and of course the JDA.

2:53 Given the customary non-disclosures, we provided as much information as we were allowed to in the press release. Let me say, however, that we are very happy to be working with this foundry partner because they're very well known in the industry for bringing innovative technologies to market. We started our engagement with them some time ago, So they are already a Phase 3 customer. Over the last year, they have used our MSTCAD modeling software to unveil some compelling new uses of MST that may enhance some of their specialty processes. Once that advantage was made clear to them through our modeling software, they immediately took steps to start running MST on device waivers. Electrical results, which validate the modeling run by this new license fee, would be a breakthrough in performance that I think they would be extremely enthusiastic about taking into production.

3:50 We also hit a significant milestone in our JDA partnership with a large semiconductor manufacturer. Very recently, we were informed that we have passed all the technical specifications required to complete the JDA. While some documentation is required before the JDA is officially completed, Our customer is satisfied that Atomera's technology meets their challenging requirements, which validates the manufacturability and the effectiveness of using MST in a world-class fab. At this point, our focus for this customer will turn towards engaging with different business units or application areas within the company to have MST integrated into their devices and hopefully taken to production.

4:37 As I have said in the past, If a business unit wants to use MSD, the next step is for us to do integration work on those specific applications. While it is hard for us to predict the required time frame, these are the opportunities that we've been looking forward to over the last year. The completion of the JDA is a revenue-bearing event, so Frank will have more to say on that in our financial section. As you can see from our engagement chart, we do remain flat with a number of customers last quarter. But during Q4, we have seen a significant uptick in the amount of activity by those customers inside Phase 3, and we believe this will continue over the next year as availability of R&D wafers and a focus on innovation returns to the industry.

5:25 We have heard feedback asking for more details of the activities within Phase 3 of our customer pipelines. Although we've considered several ways to do this, given the highly competitive nature of our industry, small disclosures by us about the details of our work can be extrapolated by knowledgeable players into competitive intelligence. I can tell you that within Phases 3 and 4, we have projects representing at least six different application areas. In some of those, we're engaged with many different customers working on very similar solutions. In others, the focus is on quite different specifications within a single broad application area, and in some applications, there may be only one or two customers.

6:11 In each of these engagements, confidentiality is vital to our customers. Our engineering team has got their hands full servicing the customer interest coming into Atomera these days. In the past, we've noticed an increase in interest by other semiconductor companies when new licensees are announced, and we think this trend is very helpful for Atomera to build our customer base in the long term. In November, Atomera announced the availability of MST SP technology which was our first design package ready for customers to adopt as a full transistor solution. We accomplished this by developing MST SP on our own wafers in our partner development fab so we can freely share all the designs and resulting data we generated.

7:01 The detailed announcement and promotional materials were very comprehensive and give us something we haven't had before, the ability to market our technology to potential customers without actually meeting them face-to-face. Although quite technical, the information was picked up by many different publications. As an example, I would point you to an EE Times article on January 26th called Quantum Engineered Material Boost Transistor Performance, which is available in the news section of our website. We hope this type of article will extend the reach of MSD and established semiconductor designers worldwide. Market reaction to the launch has been quite good. We have seen excellent incoming interest on this technology.

7:48 We are hopeful that MSDST, which is targeted at 5-volt devices, will gain strong traction, will be introduced into new fab capacity being added at legacy nodes and will become a new standard for the industry. The economic benefit of this technology is very compelling for all members of the value chain, and we will continue to deliver that message until we get customers into production. We also continue to see strong interest in MST focused at RFSOI, which is a technology fundamental to the success of the 5G cellular market. Atomera has a large body of simulation results and diffusion blocking data to prove that our technology will have significant performance benefits for RFSOI devices, which has led us to having multiple engagements underway in this area.

8:40 Earlier, I spoke about how our newest licensee used MSTCAD to model a big improvement in device performance using our technology. This is an example of how MSTCAD is becoming a more and more important tool for Atomera, especially in the earlier parts of customer engagement when they're trying to understand how best to integrate MST into their products. MSTCAD is a tool that sits on top of the market-leading industry TPAD tools made by Synopsys, so it's vital that we work closely with them as a partner. Synopsys believes in Atomera because they understand the complex physics behind our film, and how it can impact devices. In March, Synopsys will be sponsoring a webinar for their worldwide PCAD user base to learn about Atomera's technology and how MS-PCAD can be used to optimize transistors.

9:32 We're very excited to leverage the marketing strength of Synopsys to bring our technology to a much wider audience. During our last earnings call, we announced that we had reached formal acceptance of our new 300mm EPI tool, and had commenced MFT deposition on wafers. I'm pleased to say that in the last three months, our epi tools have been utilized for multiple customer wafer runs and the operations of these tools is meeting all of our expectations. Now I'd like to provide some thoughts on the overall semiconductor manufacturing environment. Industry analysts seem to have a wide ranging set of estimates for when capacity constraints in the semiconductor industry will start to dissipate. generally falling sometime from Q3 of this year into 2023.

10:22 As you know, Atomera has been affected by these fab constraints in a few different ways. Essentially, when customers can't run wafers or add tools, they do not prioritize development that requires those resources. I'm pleased to report that Atomera is currently engaged in a large number of different R&D runs with customers in Phase 3 of our pipelines. And we believe that this indicates the development pendulum is starting to swing away from dealing with supply issues and back to new technology development. As you can imagine, this is a very beneficial trend for us. We also believe it's a strong vote of confidence in Atomera's technology when companies with very limited R&D wafer capability are allocating it to development using MSP technology.

11:13 We continue to see very strong CapEx growth by almost all players in the semiconductor industry. Inevitably, the most advanced nodes are getting a lot of that CapEx, but legacy nodes are now starting to get long overdue attention, with capital directed towards building new factories or expanding production in existing fabs to correct long-term capacity issues. Today's Intel announcement of the tower acquisition is a good example of this type of investment. We believe this allocation of capital provides a very strong opportunity for Atomera since MSD can uniquely enhance older nodes that have run out of other options. Our MSD SP product is a great example of how our technology can be used to improve both performance and die size and therefore capacity in a legacy fab.

12:06 We are at the beginning of an unprecedented period of CapEx growth in the semiconductor industry and with that growth come exceptional opportunities for Adamera. I think you can agree that the last three months have been very productive for Adamera. Our company achieved several important milestones, including publicly announcing MSDSB, reaching 300 patents granted and pending, inclusion in the Forbes list of best American small companies for 2022, and more recently announcing a new license for the foundry, and fulfillment of the technical milestones specified in our JDA. We are clearly entering 2022 with strong momentum, which is something we hope to carry forward through the remainder of the year.

12:53 Now Frank will review our financials.

13:04 Thank you, Scott. At the close of the market today, we issued a press release announcing our fourth quarter and full year 2022 results. This slide shows our summary financials. Our gap net loss for the year ended December 31, 2021 was $15.7 million or 70 cents per share compared to a net loss of 14.9 million or 79 cents per share in 2020. Revenue increased by $338,000 from $62,000 in 2020 to $400,000 in 2021. GAAP operating expenses were $15.9 million in 2021, which was an increase of $960,000 from $15.0 million in 2020. Non-GAAP net loss to 2021 was $12.5 million, and reflected $12.9 million in non-GAAP operating expenses.

14:06 In 2020, our non-GAAP net loss was $11.7 million, the same as our non-GAAP operating expenses for that year. Stock compensation expense, which is the largest component of non-GAAP costs, was $3 million in both years. Our press release and this slide contain a reconciliation between our GAAP and non-GAAP results. In the fourth quarter of 2021, our GAAP net loss was $4.2 million, or 18 cents per share, compared to a net loss of $3.9 million, or 19 cents per share, in Q4 of 2020, reflecting higher operating expenses. Sequentially, the Q4 net loss since 2021 was approximately flat compared to Q3.

14:56 On a non-GAAP basis, and others. The $3.4 million in non-GAAP net loss in Q4 was unchanged sequentially from Q3 2021. Focusing now on the components of operating expenses, our full-year research and development expenses in 2021 were $8.8 million. An increase of $355,000 from $8.4 million in 2020. This increase was mainly due to the new EpiTool lease, which we started making payments on in August of 2021.

15:44 General and administrative expenses increased to $6.2 million in 2021 from $5.6 million in 2020, mainly reflecting higher insurance and payroll costs. Sales and marketing expenses in 2021 were $986,000 compared to $921,000 in the prior year. Our cash balance at the summer 31, 2021 was $28.7 million compared to $37.9 million at the end of 2020. The $9.2 million decline over the year reflects $12.4 million of cash used in operating activities. offset by $3.3 million of cash received from financing activities.

16:33 As of December 31, 2021, we had 23.2 million shares outstanding. Last year, we recognized $400,000 of manufacturing license revenue when we transferred our MST recipe to our JDA partner. The JDA also included technical objectives which, if achieved, would result in incremental revenue of $300,000 to us. As Scott mentioned, we have now completed those practical objectives. And revenue recognition depends on receiving final documentation, which is likely to happen in Q2 2022, though it could happen in Q1, depending on our partner's internal process.

17:19 Likewise, timing of revenue recognition under the new integration license is dependent on delivery of wafers and other factors. So our estimate is that revenue for Q1 will be between $0 and $25,000, and that the remaining JDA revenue will be recognized in Q2 of 2022. Our non-GAAP operating expenses for 2021 were $12.9 million. At this time last year, my guidance for 2021 OPEX was a raise of $14 to $14.5 million, which was based on two assumptions that played out differently from what we had been expecting back then. First, we had assumed that we would accept the tool and start making lease payments on it in Q1 of 2021.

18:12 As the year progressed, We provided updates on delays related to the tool, and ultimately, we only reached final acceptance in August. Secondly, we did not grow our headcount at the rate we originally anticipated. But now, the lease payments of $150,000 per month are part of our baseline R&D expenses, and we are actively hiring, primarily in engineering. Based on these assumptions, we expect that our 2022 non-GAAP operating expenses will be in the range of $15.25 to $15.75 million. Earlier today, we filed a universal shelf registration statement on Form S3 with the SEC. We had put up a similar shelf registration in 2019, and those facilities have a term of three years.

19:06 With that, I will turn the call back over to Scott for a few summary remarks before we open the call-up questions. Scott?

19:15 Thanks, Frank. The successes Atomera is experiencing as we enter into 2022 are based on the solid and impressive work our team accomplished in 2021. Early in the year, we announced our JDA and the execution of our first manufacturing license. In parallel, we were busy creating strong positions in several specific technology areas, which we announced to customers over the year, including RFSOI, IK Melgate, Advanced Nose, and finally our public release on MSTSP. We solidified our development and customer support capabilities with MSTCAD and our new world-class FU facility, which gives us the ability to get customers through the integration process and to market more quickly than ever before.

20:04 Atomera's quantum engineered technology is cementing its reputation over a broad swath of the semiconductor industry, and we hope to continue expanding it. We believe customers will take advantage of the upcoming industry investment cycle to incorporate Atomera's technology and expand their competitive advantage in the market. Inside Atomera, both our management and engineering teams are optimistic. Count on us to continue this momentum throughout the year to establish Atomera as a technology licensing leader in the semiconductor industry. And I will look forward to sharing those successes with you Mike will now take questions.

20:45 Okay, thank you, Scott. If you wish to ask a question, please click the Q&A button at the bottom of the Zoom window and then feel free to type in your question. I will do my best to aggregate the incoming queries and relay them to management. Alternatively, you can click the raise hand button and we may call on you live. So right now, our first question comes from Richard Shannon of Craig Hallam. Richard, you may unmute and turn on your camera if you wish.

21:16 All right, there we go. Thank you, Mike. And Scott and Frank, thanks for taking my questions. A lot of good stuff to ask about here. Let's see here. Let's start with the GADA, where you said you met all of the technical requirements. So I guess I'd love to understand and characterize what happens next year. Obviously, we've got a constrained environment here from a test point of view with these business units you talk about. How fast can we move with any particular business unit towards a more complete agreement in getting to production there? And what do you think is more realistic in this environment?

21:53 Yeah, thanks, Richard. I'm pleased to share a little more detail on the JDA. So when we entered into the JDA, the way it was structured was Central Engineering Group and said they're going to evaluate our technology for a number of things, importantly for manufacturability and for how well it actually performed in doing the things that we have been saying it could do. And so they wrote some specifications and they said when you guys pass those specifications, then we can start sharing your technology with different business units. And so what's happened now is that we've actually officially passed those specifications. Now, we did not officially complete the JEA, which is a paperwork thing, but the important thing is our technology has been proven to do what we said it would do.

22:49 Now we'll engage with different business units, at least I hope we will. That's our intent. We're starting to talk to some about integrating MST. And when they do that, We'll start going through a normal integration process like we do with many customers where we help them figure out how to put our technology into their designs. And then they will probably run wafers to see what the impact is. The timeframe for doing that is always hard to predict. But I can say in the case of this JDA, the customer has got MST installed in their factories. So it should be much faster for them to perform integration than it would be for a customer that's flying wafers around the world to get MST deposited by us and then sending them back. That can put months of delays into the process.

23:43 So it could be fast. They move very quickly.

24:03 So with this JDA customer having MST installed, how many cycles can they do a year? Can they do three or four even more non-overlapping cycles, or is it not that optimistic?

24:16 You know, they can do cycles very quickly. It's hard to say, Richard, because as you know, in older process nodes, It might take just a couple months to run through a full cycle. In the newest process nodes, it can take a very long time. And so we're not exactly sure where they will be using this. I hope they'll be using it in multiple different areas. But just to give you an idea about how much time they would save over sending us the wafers, normally someone, it probably takes two months to take The wafers out of your fab, package them up, send them to us. We do all of our testing and make sure everything's nice and clean. We do MST depositions, package it all up, send it back to them. They have to do a whole bunch of testing to make sure everything is clean and not contaminated, and then find time to slot it into their production line. That whole process I just talked about can take two months, sometimes even three months, but since MST is installed in that factory, it can literally take a half an hour or less for them to deposit MSD and continue moving it down the line. So it can save a lot of time.

25:28 Okay. Fair enough then. Scott, I may have missed this, but I know in the last call you talked about kind of expanding the ADA pipeline. Can you characterize the pace in the last quarter?

25:42 Yeah. Richard, you're right. I didn't talk about that on the call, so you didn't miss it. I'll continue to say the same thing. We still have a number of JDA customers that we are continuing to talk to and we are hopeful that those will turn into actual JDA agreements sometime over the course of this year.

26:04 Okay. Let's jump over to the foundry license you announced last week. I know you haven't given much detail other than announcing it's a foundry license. I think you said in your prepared remarks it is a customer that is in has been in phase 3, 4, or wild. Did I catch that correctly? That's correct, yeah.

26:24 Okay. Can you characterize how long you've been engaged with them in any way to help us think about this?

26:31 Yeah, I would say we've been engaged with them for a few years now. And we've done some experiments and now the so it's kind of more of a Concept Experiments. And so now, as I talked about in the script, they did a bunch of work on our NFDCAD tools to focus down on one particular applications area they got very excited about. We are talking to them about multiple different applications areas.

27:03 Okay. And this is your first foundry license that I recall. Please correct me if I'm wrong there, but Scott Bibaud, Robert Mears

27:39 fabulous design companies around the world designing chips that can be used in our process and that's quite exciting to us. What we found in the past is that some foundries are resistant to making a lot of changes to their own processes unless there's an end customer that's bringing in the demand for that and so So whereas if you can get a foundry to adopt your technology, it's a massive opportunity, but sometimes it's harder to get them to adopt it unless you bring a lead customer with you who's very interested in your technology and kind of says, please, you know, please take this stuff on. One of the reasons why when we talked about our MSDSP public announcement and the rollout we did in November, that's so exciting because it's starting to go out to fabulous designers. So they can learn what they would get from MSCSP, and then they can go to their foundry partners and tell them, you need to adopt Adam Mears MSC technology so we can get these benefits.

28:48 Okay. Are you trying to draw a line between MSCSP and this foundry license, Scott, or are you just noting that general opportunity?

28:55 No, I'm not. I'm not making any connection whatsoever between the two.

28:59 Okay. Okay. Fair enough then. My last question, I'll jump out of line here, Scott. I may not have caught your comments directly here, but I think you said you're pleased to report that you've done a large number of R&D runs with a lot of companies in Phase 3. I think it's towards the end of your prepared remarks. Can you help us understand kind of the scale of improvement, either in terms of number of wafer runs or customers doing this, or just more detail behind that comment?

29:28 Yeah, you know... In this period of the capacity constraints, probably for a year and a half now, we continue to work with customers, and we'd be working with them on MSC CAD and planning and other things, but their ability to start wafers has been quite constrained. So maybe they would say, you know, we have this great idea we'd like to explore, but for the time being, we just can't run wafers to do it, so we'll have to do it through other engineering analysis. Suddenly, In the last three months, three or four months, I'd say, we've started to see that shift and shift across a number of different customers where they're suddenly saying, okay, we can run wafers now.

30:13 We want to run wafers quickly. So, as I mentioned, our EPI tools both are new and all of our EPI tools are being well utilized now, many of them for customer runs on R&D lines. So, we view this as a little bit of a barometer of the industry, as I said in my remarks, not only having a little bit more room to be able to run R&D wafers, but also starting to really get more serious thinking about product innovation instead of just trying to solve capacity issues.

30:51 Okay. Very interesting comments. I'm going to jump on the line and let others ask some questions, but I appreciate the time. Thanks a lot, guys.

30:59 Thanks, Richard.

31:02 Thank you, Richard. Now, I will aggregate some questions coming in from the audience. And again, if you have questions, feel free to type them into the Q&A button at the bottom of the Zoom window. So the first question that I have rolling in is, Can you give us an update on the prior licensees we mentioned in the press release? We've got five now licenses that we've announced. The question is, can you provide an update on some of the prior ones and how the progress is going there?

31:41 Yeah, so obviously we can never give detailed results on our licensees, but I can say that We continue to work actively with all of our existing licensees and planning and running waivers with them with one exception and that I have talked to you guys about before is our Japanese licensee AKM. A little more than a year ago they had a fire in their factory and they're still recovering from that and so their R&D efforts are really been put on hold for the time being. We do have an agreement with that customer that when they're recovered and they'll start those efforts back up with us, and so we'll start going again.

32:33 Otherwise, we continue working very strongly with all of our existing licensees and hopefully moving closer to production all the time.

32:41 All right. And another question here is, do you see traction more coming from legacy semi, or are you seeing – Traction from Fabulous Semiconductors companies as well.

32:54 I would say we're seeing a mix, but we still, you know, our sales efforts have been focused around IBMs and boundaries in the past, so I would say the majority of the work we're doing is there, but we're starting to see more and more work going on with the Fabulous Semiconductor companies, and it's a focus that we're going to try to expand. One thing to just understand is that the universe of interesting IDMs and foundries is probably 50 or less companies and so we do have a good ability to reach out there with our direct sales team and be able to address them. The universe of fabulous companies is in the hundreds.

33:42 300,400 different companies and so it's a little more challenging and that's one of the reasons why we're trying to use broad reach methods like public relations and articles and journals and things like that. So we'll combine that with our direct Salesforce efforts as well.

34:03 All right. And then, Frank, a question for you about the form, the SEC form, the file. Can you give us a little bit more detail on the shelf registration and if there's any plans?

34:20 Yeah, I'm happy to do that. So we had a shelf registration statement that we filed in 2019, and under the SEC rules, the S3 registration statement has a life of three years. So I consider it just good practice to always have an available shelf registration statement to take advantage of opportunities if we see them. So it was just a question of renewing that facility right now.

34:54 Okay. And a high-level question here. At what point is a JDA classified as Phase 5, and what does that look like in me?

35:09 Yeah. Regardless of whether it's a JDA or a licensee, Phase 5 is when a customer enters process qualification, and that's a pretty well-defined term in the semiconductor industry. If you have a new manufacturing process that you're going to take to production, you have to run it through a series of tests to test all the many corners of production variation you might be receiving with your tools. That takes a while to do. In our experience, it takes from 9 to 12 months. But generally, and it's a relatively expensive process. So if a semiconductor company enters into process qualification, they're almost always going to take that process to production.

35:58 Obviously, one of the most important steps for our customers to take before they go to production is to enter into process qualification, whether they're a straight licensee or a JDA partner of ours. and we'd be doing so as they enter into process qualification and get serious about selling the product we need to be finalizing negotiation of our distribution license with them which would give them the rights to sell products using our technology and it would also define the royalty rates it would be receiving with them so if we were if we were ever to close one of those distribution licenses obviously that would be very big news and we'd be letting you know about it as soon as possible

36:42 Okay, great. Thanks. And then a question about the new licensee, given that it's a foundry, did one of their customers lead you to the foundry or did you approach the foundry directly? And adding on that, do you have to do separate license agreements with the end customer through the foundry?

37:09 Okay. So first, on this particular foundry, we engaged with directly, as I mentioned a few years ago, and have been exploring a number of different areas with them. Although we also have spoken with some of their customers, but if the question is who was responsible for kind of initially getting us in there, I would say it was direct to the foundry. And the last part of the question, Mike?

37:38 was whether there's a separate license agreement with the end customer.

37:43 That's a great question. There's actually some technical structures where there would be a license with both the fabulous customer and with the foundry that they use. But in most cases, the vast majority of... Fabless Semiconductor Makers use a process that's owned by the foundry. And in that case, the foundry would have a license with us to manufacture and sell their own foundry process. In the case where a Fabless customer might have a proprietary process, their own proprietary process running at a foundry, then they would be a licensee with us and so would the foundry.

38:29 Okay, and our last question is, talks about MSTCAD and if you've seen an uptick of activity with MSTCADs and what metrics do you use to determine whether the MSTCAD is impactful into the penetration into the market?

38:48 Yeah, MSTCAD, we definitely have seen a lot more customers come in. MSTCAD is definitely not like a generally off-the-shelf product. It's extremely technical, and we made it and continue to make it easier to use, but it does require a lot of hand-holding by our team to help them get the technology properly integrated into their PCAD stack and to interpret the results. And we're constantly improving that and making new releases that improve the usability of it. I can tell you that our engineering team is supporting more and more customers and I don't think at this time it would be possible for customers to be playing with MSD CAD without working with us. So yeah, we have pretty good metrics on how many customers are using it and what they're using it for and we're very pleased with its uptake.

39:49 Great.

39:50 And Scott, feel free to proceed with any closing comments you may have.

39:56 All right, Mike, thanks. And thank you all for attending today's presentation. It's really been good to be able to share with you some of the information on our recent efforts and to give you a feeling of the enthusiasm we are experiencing inside Atomera. Please continue to look for our news, articles, and blog posts to keep you up to date on our progress. You can sign up for them along with investor alerts on our website, atomera.com. We look forward to seeing some of you during our scheduled marketing activities. So if you have additional questions, please contact Mike Bishop. We'll be happy to follow up. Thank you again for your support, and we look forward to our next update call.

40:37 Thanks, Scott. And at this time, this concludes the webinar for today.

Follow Atomera Incorporated into a list and get an email when it puts out news.

Latest news releases

Companies on this call

Speakers

Mike Bishop

Investor Relations

Scott Bibaud

President and CEO

Frank Laurencio

Chief Financial Officer

Richard Shannon

Analyst, Craig Hallum

More from Atomera Incorporated